About 1 result found for searched term "Canlitinib" (0.272 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M43488 | Canlitinib | c-Met |
| Canlitinib is a tyrosine kinase inhibitor, extracted from patent WO2018072614 (IV-2). | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
